deal, page-32

Just a side thought, assuming a more than favourable outcome from this TH for Cynata, it might wake up the market not just to CYP but the broader ASX Bio sector. People could be chasing 'the next CYP'. That's not to say that CYP doesn't have seemingly endless growth ops from current position, but we see it all the time in other sectors. Remember when just the slightest whiff of 'lithium' in an announcement would send a stock soaring? It had a big flow on effect. Never know, might see a greater overall interest start building in the Bio/Regenerative health sector. I welcome it.